Image

Study on Biomarkers of Periodontitis and Type 2 Diabetes Mellitus in Males and Females 30 - 70 Years of Age

Study on the Effect of an Investigational Medication on Diabetes and Gum Disease

Recruiting
30-70 years
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates the effects of an investigational medication on individuals with Type 2 Diabetes Mellitus (T2DM) and periodontal disease (PD). Type 2 diabetes is a condition where the body does not use insulin properly, leading to high blood sugar levels. Periodontal disease, also known as gum disease, is an infection of the tissues that hold your teeth in place. The study aims to understand how these conditions interact with the investigational medication.

Participants will undergo a screening visit followed by a single visit for specimen collection. During the study, participants will be monitored for changes in their condition and any effects of the investigational medication. The study will involve collecting samples to assess the impact of the treatment on diabetes and periodontal health.

  • Who can participate: Adults aged 30 to 70 years with a body mass index less than 40 kg/m2 are eligible. Participants must not have pre-diabetes and should have specific stages of periodontal disease or Type 2 Diabetes Mellitus for at least 6 months.
  • Study details: The study involves monitoring changes in health conditions and the effects of the investigational medication. A placebo may also be used.
  • Study Timelines and Visits: The study will last up to 30 days. The study requires 2 visits.
Print
Study details
    Periodontal Disease

NCT06582056

Sanofi Pasteur, a Sanofi Company

14 May 2025

Contact a study center
Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
This helps us to contact you based on your preferred way of contact
Other language

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.